Imlunestrant
C29H24F4N2O3 — CID 146603228
View drug profile → imlunestrantData last refreshed: (MolForge compound catalog, from PubChem)
About Imlunestrant
Imlunestrant (PubChem CID 146603228) has the molecular formula C29H24F4N2O3 and a molecular weight of 524.51 g/mol. Its IUPAC name is (5R)-5-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-8-(trifluoromethyl)-5H-chromeno[4,3-c]quinolin-2-ol.
Molecular Properties
| Compound Name | Imlunestrant |
|---|---|
| PubChem CID | 146603228 |
| Molecular Formula | C29H24F4N2O3 |
| Molecular Weight | 524.51 g/mol |
| Exact Mass | 524.17 |
| IUPAC Name | (5R)-5-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-8-(trifluoromethyl)-5H-chromeno[4,3-c]quinolin-2-ol |
| SMILES | Oc1ccc2c3c(cnc2c1)-c1ccc(C(F)(F)F)cc1O[C@@H]3c1ccc(OCCN2CC(CF)C2)cc1 |
| InChI | InChI=1S/C29H24F4N2O3/c30-13-17-15-35(16-17)9-10-37-21-5-1-18(2-6-21)28-27-23-8-4-20(36)12-25(23)34-14-24(27)22-7-3-19(29(31,32)33)11-26(22)38-28/h1-8,11-12,14,17,28,36H,9-10,13,15-16H2/t28-/m1/s1 |
| InChIKey | UVBQMXOKKDCBJN-MUUNZHRXSA-N |
| XLogP | 6.39 |
| TPSA | 54.82 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 524.51 |
| LogP ≤ 5 | 6.39 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Related Compounds
Frequently Asked Questions
Browse: Molecules: I · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146603228 — identifiers, structure, computed properties (public domain)
- DrugCentral drug card 5783 — approved-drug record (CC BY-SA 4.0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.